GLP-1 Drugs Show Potential in Reducing Type 2 Diabetes Risk for Prediabetics | Retatrutide News

GLP-1 drugs may reduce type 2 diabetes risk in prediabetic individuals, expanding their potential use beyond obesity treatment. Eli Lilly's involvement ...
Clinical Trials · November 3, 2026